[Form 4] Upstart Holdings, Inc. Common stock Insider Trading Activity
Rhea-AI Filing Summary
Dave Girouard, CEO and director of Upstart Holdings, Inc. (UPST), reported transactions on 08/15/2025 executed pursuant to a Rule 10b5-1 trading plan adopted August 29, 2024. He exercised an employee stock option to acquire 41,667 shares at an exercise price of $0.83 per share and immediately sold those shares in multiple transactions. The Form 4 reports sales of 38,777 shares at a weighted-average price of $63.2267 and 2,890 shares at a weighted-average price of $63.9072. Following these transactions Girouard beneficially owns 52,614 shares directly and holds additional shares indirectly through trusts and entities as disclosed on the form.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, adopted August 29, 2024, which can provide an affirmative defense to insider trading claims.
- Exercise of fully vested options (41,667 shares at $0.83), indicating option terms were satisfied before exercise.
- Transparent reporting of weighted-average sale prices and an undertaking to provide per-trade price details upon request.
Negative
- Reduction in direct beneficial ownership to 52,614 shares following reported sales on 08/15/2025.
Insights
TL;DR: CEO exercised vested options and sold the acquired shares under a 10b5-1 plan; transaction appears routine.
The Form 4 shows an exercise of an employee option for 41,667 shares at $0.83 and contemporaneous sales that generated proceeds at weighted-average prices of $63.2267 and $63.9072. The sales were effected under a pre-established Rule 10b5-1 plan, which provides an affirmative defense to insider trading claims when properly adopted. The transactions reduced Girouard's reported direct holdings to 52,614 shares while numerous larger indirect holdings remain in trusts and LLCs as disclosed.
TL;DR: Governance practices observed include use of a documented 10b5-1 plan and timely Form 4 reporting.
The filing explicitly states the trades were executed pursuant to a 10b5-1 plan adopted on August 29, 2024, and provides weighted-average sale prices with an offer to disclose per-transaction price details on request. The form discloses multiple indirect ownership interests through trusts and a GRAT, and notes the option shares were fully vested and exercisable as of the transaction date—consistent with standard executive equity management and disclosure protocols.